Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-53.34	7.41	15.88
Graham Fair Price	41.42	7.20	5.09
PEG	133.63	-0.01	< 0.005
Price/Book	-15.46	0.06	0.07
Price/Cash Flow	-39.63	6.28	10.41
Prices/Earnings	57.73	-1.28	-3.02
Price/Sales	-57.73	1.18	2.80
Price/FCF	-39.63	6.28	10.41
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-42.46	0.29	0.50
Operating Margin	0.00	0.21	0.21
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	-0.01	-100.00
ROIC	0.02	0.04	100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	< 0.005	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.16	1.00	520.52
EPS QOQ	-5.49	-0.99	81.91
FCF QOQ	2.14	0.40	-81.26
Revenue QOQ	-0.29	1.00	241.39
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1.78	0.63	-64.89
Days Sales Outstanding (DSO)	10.44	5.99	-42.61
Inventory Turnover	50.44	143.64	184.78
Debt/Capitalization	0.12	0.12	0.00
Quick Ratio	1.42	1.44	0.86
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	14.34	14.34	< 0.005
Cash	0.65	0.65	< 0.005
Capex	-0.03	-0.05	-100.00
Free Cash Flow	0.09	0.13	40.04
Revenue	0.35	0.69	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.49	1.49	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.27	4.62	-50.13
Naive Interpretation	Member

06 - Financial Health · Weak

Rating